Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents

Platelets

Volumn 19, Issue 1, 2008, Pages 24-31

  Zhao, Lian ^a   Gaudry, Leonie ^a   Dunkley, Scott ^a   Brighton, Tim ^a   Guo, Zhi Xin ^b   Ye, Zheng Liang ^a   Luo, Run Zhi ^b   Chesterman, Colin N ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Tianjin Tasly Group Co Ltd   (China)

Author keywords

Leucocyte function; Platelet function; Salvia miltiorrhiza

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CANGRELOR; CHINESE DRUG; DAN SHEN DI WAN; DANTONIC; SALVIA MILTIORRHIZA EXTRACT; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG MECHANISM; HERBAL MEDICINE; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE FUNCTION; MEDICINAL PLANT; MONOCYTE; PRIORITY JOURNAL; SALVIA; SALVIA MILTIORRHIZA; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ANTIOXIDANTS; ATHEROSCLEROSIS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; ISCHEMIA; LEUKOCYTES; MALE; PLANT EXTRACTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

SALVIA MILTIORRHIZA;

EID: 38649125545     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701286123     Document Type: Article

References (26)

1. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378-3384.
2. Barnard MR, Linden MD, Frelinger AL, Li Y, Fox ML, Furman MI, Michelson AD. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity. J Thromb Haemost 2005;3:2563-2570.
3. Phillips DR, Conley PB, Sinha U, Andre P. Therapeutic approaches in arterial thrombosis. J Thromb Haemost 2005;3:1577-1589.
4. Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005;45:1345-1359.
5. Tianjin Tasly Pharmaceutical Group Co. Ltd.. Approval of Compound DanshenDripping Pill (DSP) by FDA through pre-IND for clinical trials. Proc Forum Internationalized Chinese Materia Medica 1998:18-30.
6. Li J, He LY, Song WZ. Separation and quantitative determination of seven aqueous depsides in Salvia miltiorrhiza by HPTLC scanning. Yao Xue Xue Bao 1993;28:543-547.
7. Hu P, Liang QL, Luo GA, Zhao ZZ, Jiang ZH. Multi-component HPLC fingerprinting of radix salviae miltiorrhizae and its LC-MS-MS identification. Chem Pharmaceut Bull 2005;53:677-683.
8. Sugiyama A, Zhu BM, Takahara A, Satoh Y, Hashimoto K. Cardiac effects of salvia miltiorrhiza/dalbergia odorifera mixture, an intravenously applicable Chinese medicine widely used for patients with ischemic heart disease in China. Circ J 2002;66:182-184.
9. Lay I, Chiu J, Shiao M, Lui W, Wu C. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med 2003;69:26-32.
10. Kim JS, Narula AS, Jobin C. Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappa B signalling in intestinal epithelial cells. Clin Exp Immunol 2005;141:288-297.
11. Zhu W, Chen G, Hu L, Luo X, Gui C, Luo C, Puah CM, Chen K, Jiang H. QSAR analyses on ginkgolides and their analogues using CoMFA, CoMSIA, and HQSAR. Bioorg Med Chem 2005;13:313-322.
12. Fox S, Sasae R, Janson S, May J, Heptinstall S. Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets 2004;15:85-93.
13. Zhao L, Bath P, Heptinstall S. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. Br J Pharmacol 2001;134:353-358.
14. Zhao L, Fletcher S, Weaver C, Leonardi-Bee J, May J, Fox S, Willmot M. Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke. Thromb Haemost 2005;93:527-534.
15. Jennings LK, Dockter ME, Wall CD, Fox CF, Kennedy DM. Calcium mobilization in human platelets using indo-1 and flow cytometry. Blood 1989;74:2674-2680.
16. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998;95:8070-8974.
17. Pulcinelli FM, Ciampa MT, Favilla M, Pignatelli P, Riondino S, Gazzaniga PP. Concomitant activation of Gi protein-coupled receptor and protein kinase C or phospholipase C is required for platelet aggregation. FEBS Lett. 1999;460:37-40.
18. Yu WG, Xu LN. Effect of acetylsalvianolic acid A on platelet function. Yao Xue Xue Bao 1994;29:412-416.
19. Chen Y, Lin S, Ku H, Shiao M, Lin F, Chen J, Chen Y. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem 2001;82:512-521.
20. Wu YJ, Hong CY, Lin SJ, Wu P, Shiao MS. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler Thromb Vasc Biol 1998;18:481-486.
21. Marcus AJ. Thrombosis and inflammation as multicellular processes: Pathophysiologic significance of transcellular metabolism. Blood 1990;76:1903-1907.
22. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
23. Libby P, Simon DI. Inflammation and thrombosis: The clot thickens. Circulation 2001;103:1718-1720.
24. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: Is it time to intervene? Arterioscler Thromb Vasc Biol 2005;25:658-670.
25. Grzybowski M, Welch RD, Parsons L, Ndumele CE, Chen E, Zalenski R, Barron HV. The association between white blood cell count and acute myocardial infarction in-hospital mortality: Findings from the National Registry of Myocardial Infarction. Acad Emerg Med 2004;11:1049-1060.
26. Gurm HS, Bhatt DL, Gupta R, Ellis SG, Topol EJ, Lauer MS. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J 2003;146:692-698.